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The absorption eﬃciency of any drug in blood is of prime importance. Compounds having the general formula:
Kn[M(FO)2(H2O)2]·xH2O, where (M = Cu(II) or Fe(III), n = 2o r1,F O= folate anion, x = 2 or 3 with respect), were prepared,
and their absorption eﬃciency in rodent’s blood was determined. The obtained compounds were characterized by elemental
analysis, infrared as well as thermogravimetric analysis and polarization of light. The results suggest that the two folate complexes
were formed in 1 : 2 molar ratio (metal : folic acid) which acted as a bidentate ligand through both carboxylic groups. Polarization
oflightprovedthatthefolatecomplexeshavesymmetricgeometry.BiologicalapplicationprovedthatCu(II)andFe(III)complexes
were absorbed more eﬃciently in rodent blood than folic acid itself.
Copyright © 2009 E. Hamed et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Folic acid as reported in the ﬁgure, N-(4{[(2-amino-
4-oxo-1, 4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-
glutamicacidisfromagroupofvitaminscalledwatersoluble
vitamins which contain B-Group vitamins and the other
group. It is fat-insoluble vitamins, acting as a coenzyme in
many single carbon transfer reactions in the synthesis of
DNA, RNA, and protein components [1]. It is called pteroyl-
L-glutamic acid (PGA), see Figure 1. The occurrence of folic
acid in nature is not in appreciable amounts, though it is
assimilatedinthebodyandisconvertedtotheactivecofactor
form of the vitamin [2]. Folic acid deﬁciency results in DNA
strand breaks [3], DNA hypomethylation [4], and abnormal
gene expression [5].
It has been shown that folic acid supplementation can
signiﬁcantly reduce the risk of these disorders [6–14]. Folates
are the key cofactors in one-carbon metabolism. Together
with other substrates and cofactors it is involved in the
synthesis of the purine ring, conversion of 2-deoxyuridine
monophosphate to thymidine monophosphate, via S-
adenosylmethionine. Over 80 methylation reactions are
known to date [15, 16]. Given the importance of one-
carbonmetabolisminabroadvarietyofmetabolicpathways,
it is not entirely surprising that abnormal, notably low,
folate status is associated with risk for seemingly unrelated
developmental anomalies and diseases, ranging from neural
tube defects, Alzheimer dementia, pregnancy complications,
inﬂammatory disease, osteoporosis and cancer to coronary
artery disease. Severe micronutrient deﬁciencies usually
cause readily recognizable symptoms, such as anemia in
folate deﬁciency, but the eﬀects of subclinical deﬁciencies
on disease development are not readily apparent, since they
usually operate over prolonged periods of time [17]. The
structural diversity encountered in metal-folate complexes
could be attributed to the versatile ligational behavior of the
carboxylate group which can function like a bidentate ligand
binding to a single metal or alternatively as a bridging biden-
tate ligand coordinating to two metals or as a monodentate
ligand [18, 19]. The three diﬀerent coordination modes were
reported in literature [20, 21]. The aim of the present work is
to demonstrate the enhancement of the absorption eﬃciency
of folic acid in blood by using biological saving metals as Fe
and Cu which already exist in human blood and also to show2 Bioinorganic Chemistry and Applications
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Figure 1: Structure of folic acid.
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Figure 2: The expected structure of the two complexes.
the way in which these transition metals combine with folic
acid. The composition and structure of the complexes were
identiﬁed using: elemental analysis (C,H,N), FTIR, atomic
absorption, light polarization, and TGA techniques.
2. Experimental:Materials
andInstrumentation
2.1. Materials. All chemicals used in the present study are
reagent grade,
(1) Folic acid, Adwic (C19H19N7O6 · 2H2O) (Figure 1)
used without further puriﬁcation.
(2) The following metal basic carbonates were used in
preparing the solid folate complexes after determin-
ing their metal content after dissolution in the least
amount of dilute nitric acid, by atomic absorption
spectrometry
(i) CuCO3 ·Cu(OH)2·H2O
(ii) Fe2(CO3)3 ·3Fe(OH)3 ·5H2O.
2.2. Instrumentation
Elemental Analysis. C, H, and N were determined at the
microanalyticallaboratory,CairoandAinShamsUniversities
using a Perkin Elmer 2400 CHN elemental analyzer. Copper
and iron were determined by atomic absorption spectrom-
etry (AAS), using Perkin Elmer AAS 3100. A given weight
of the complex was heated with concentrated nitric acid
nearly to dryness. The resulting metal nitrate was dissolved
in distilled water and the solution made to volume in a
measuring ﬂask. Standard metal solution series is prepared
by diluting calculated volumes of a standard stock solution
of the metal to the mark in a volumetric ﬂask. The hollow
cathode lamp of our metals concerned are used, the current
adjusted to the recommended value and the metal line.
(λnm) is selected to give the maximum absorption using
the appropriate monochromator slit width. The absorbance
of the sample is read and the concentration of the metal is
determined from the calibration curve constructed from the
absorbances of the standard solutions.
Atomic Absorption Measurements. Thermogravimetric anal-
ysis was carried out using a Perkin-Elmer 7 Series thermal
analyzer. The measurements were carried out under nitrogen
atmosphere at a heating rate 10◦C/min.
Optical Measurements. Polarimetric measurement was
recorded on a Courtesy Messrs, Hilgher and Watts, Ltd.,
London polarimeter. The ﬁeld of view appears dark (which
occurs when the axes of the two prisms are at right angles to
each other).
I.R. Spectra. I.R. spectra of the solid complexes were
recorded on a Perkin-Elmer spectrometer Model Jasco FTIR-
300E Fourier Transform Infrared Spectrometer, using KBr
discs in the range 400–4000 cm−1.
Solubility. The solubility of the prepared complexes was
determined by shaking few milligrams of the complex
with about 25mL of aliquots of distilled water in a water
thermostat at 25◦C ± 0.2 for about 3hours. The suspension
was rapidly ﬁltered and measured aliquots of the ﬁltrate
titrated against standard HCl solution using methyl orange
as indicator (Table 1).
Synthesis of Metal Complexes. Cu-folates, K2[Cu(FO)2
(H2O)2] · 2H2O (the complex color is yellowish green). The
complex was prepared by mixing (0.1mol) of the metal
carbonate with 0.2mol of folic acid in ∼50 mL of distilledBioinorganic Chemistry and Applications 3
Table 1: Elemental analysis and solubility of the complexes.
Metal complexes Solubility (g/L) Metal C H N
Cal % Found % Cal % Found % Cal % Found % Cal % Found %
K2[Cu(FO)2(H2O)2]2H2O(yellowish green) 2.18 g/L 5.83 6.09 41.85 41.08 3.67 3.27 17.99 16.30
K[Fe(FO)2(H2O)2]3H2O(dark brown) 1.67 g/L 5.47 4.87 42.98 42.29 3.83 3.36 18.47 17.91
water. (The pH of the folic acid solution is adjusted to about
7.6–7.8 by adding 0.2M of KHCO3 solution and warmed
at about ∼60◦C before adding the metal carbonate). After
complete reaction, the solution was concentrated to about
25mL, it was then cooled in ice-cold water where crystals
of copper folate complex separated out on addition of little
ethyl alcohol, ﬁltered and recrystallized from warming water,
washed with ethyl alcohol and kept in a vacuum desiccators
over dried silica gel. Fe-Folates, K[Fe(FO)2(H2O)2] · 3H2O
(the complex color is dark brown). A similar procedure as that
described for copper folate complex was carried out, for the
preparation of the 1 : 2 iron complex.
Ethical Considerations. All animal experimental procedures
had full approval from the Animal Ethics Committee of
Menouﬁa University.
Animals. White albino mice were obtained from the experi-
mental animal house of the Genetic Engineering & Biotech-
nology Institute, Menouﬁa University.
All mice had free access to commercial pelleted food
and tap water. The mice were maintained at an ambient
temperature of 22◦C with 12hours light/dark cycles.
Drug Administration Procedure. A group of male mice was
given orally 100mg/kg body weight of folic acid or its com-
plexes (copper-folate and iron-folate), all preparations are
dissolved and suspended in distilled water, ﬁve individuals
were used for each treatment of folic acid and its complexes.
Two hours after treatment mice were killed and plasma
collected for investigations.
3. Results andDiscussion
Results of elemental analysis and some physical character-
istics of the obtained complexes are shown in Table 1.T h e
complexes are air stable, and they have high-melting point.
Their solubility in water is ∼ (10
−1 mol) in H2O. Elemental
analysis data of the complexes indicate that the complexes
have the 1 : 2 stoichiometry (metal : ligand) with general
formulae shown in (Table 1).
3.1. Optical Measurements. The polarimeter consists of a
monochromatic light source, a polarizer, a sample cell, a
second polarizer, which is called the analyzer, and a light
detector. The analyzer is oriented 90
◦ to the polarizer so
that no light reaches the detector. When an optically active
substanceispresentinthebeam,itrotatesthepolarizationof
the light reaching the analyzer so that there is a component
that reaches the detector. The angle that the analyzer must be
rotated to return to the minimum detector “α” signal is the
optical rotation angle.
Polarimetric measurements on solutions of the two
complexes showed that both complexes possess no angle of
rotation (α = 0), that is, having plane of symmetry. It is thus
concluded that they have an octahedral structure with two
trans coordinate water molecules, as shown in Figure 2.
3.2. Infrared Spectra. The essential infrared data are summa-
rized in Table 2. Folic acid exhibits a very strong absorption
bandat1718cm−1 duetothestretchingvibrationofν(C=O)
of free ketonic of the carboxylic group [21]. This group
is shifted or disappeared in the spectra of its complexes
accompanied by the appearance of two bands in the 1569–
1631cm−1 range due to νas(COO−) and one in the 1350–
1413cm−1 range assigned to νs(COO−). Accordingly, the
antisymmetric and symmetric stretching vibration modes
(νas(COO−)a n dνs(COO−)) of the COO− group should
help in elucidating the structure of our complexes [22].
The direction of the frequency shift of the νas(COO−)
andtheνs(COO−)bandswithrespecttothoseofthefreeion
depends on the coordination mode of the COO− groupwith
the metal ion. Nakamoto and McCarthy [21, 23]c l a i m e d
that if the coordination is monodentate the νas(COO−)a n d
νs(COO−) will be shifted to higher and lower frequencies,
respectively. Whereas, if the coordination is chelating biden-
tate or bridging bidentate both νas(COO
−)a n dνs(COO
−)
frequencies will change in the same direction. This is because
the bond orders of both C=O bonds would change by
the same amount. Based on these facts and comparing
the νas(COO
−)a n dνs(COO
−) frequencies of the folate
complexes by the νas(COO
−)a n dνs(COO
−)f r e q u e n c i e so f
potassium carboxylate [24], as shown in Table 3 and Figure 2
one can say that all the prepared complexes are metal chelats
in contradistinction to what is described in [21], because
both νas(COO
−)a n dνs(COO
−)f r e q u e n c i e sw i l lc h a n g ei n
theoppositedirectionthisindicatesthatthecarboxylicgroup
is monodentate coordinate. The broad stretching vibration
of OH
− group ν(O–H) occurred as expected [25]a t∼
3397cm−1. The amide fragments are shown in (Table 2)b y
i.r. about 3200 cm−1 (ν NH), in 1652–1658 cm−1 region
(ν(C=O) amide I), and about 1520 cm−1 (δ(NH) amide II)
[26–28].
3.3. Thermogravimetric Analysis. T h e r m a la n a l y s i sc u r v e s
(TG/DTG) of folic acid and its transition metal complexes
are studied and interpreted as follows. The folic acid ligand
melts at 220◦C with simultaneous decomposition [20, 21].
From the TG curve for copper folate complex (Figure 4), it
appears that the sample decomposes in four endothermic4 Bioinorganic Chemistry and Applications
Table 2: IR frequencies (Cm1 ) of folic acid (FO) and its metal complexes.
Assignments Compounds
Folic acid Fe-folate
complex
Cu-folate
complex
ν(OH); H2O 3421
3415 3381 3388
ν(NH) amide 3230 3175 3220
νas(CH) 3106
2926
3090
2930
3030
2930
νs(CH) 2840 2820
2770
2830
2805
ν(C=O) amide I 1652 1658 1655
ν(COOH) 1718 — —
νas(COO−) 1569 1613 1603
δ(CH) 1483
1413
1448
1401
1445
1400
νs(COO−) 1453 1369 1350
δ(NH) amide II 1528 1520 1532
νas(CC) 1323 1303 1300
ν(CN)
1230
1191
1106
1185
1106
1186
1102
νs(CC) 971 980 955
δ(CC) 764 767 766
ν(M–O) — 587
520
585
521
Table 3: Asymmetric and Symmetric Stretching Vibrations of the Carboxylate group.
Compound νas(COO) νs(COO) ν = νas(COO
−) −νs(COO
−) Bonding mode
Folic acid 1569 1453 116 —
K[Fe(FO)2((H2O)2] ·2H2O 1631 1369 262 Mono dentate
K2[Cu(FO)2(H2O)2] ·2H2O 1603 1350 253 Mono dentate
Table 4: The concentration of Cu and Fe elements in mice blood serum in case of folic acid and folic acid metal complex.
Elements
Cu (mg/L)
(after inject of
folic acid)
Cu (mg/L) (after
inject complex)
Fe (mg/L) (after
inject of folic
acid)
Fe (mg/L)(after
inject complex)
Mice 1 5.1 6.4 7.9 12.4
Mice 2 4.8 6.9 8.3 13.2
Mice 3 4.9 7.6 7.7 11.8
Mice 4 5.1 7.2 9.2 14.7
Mice 5 5.1 6.9 10.2 16.9
Table 5: Comparison between the normal, folic acid case and folic acid metal complex case percentage of Cu and Fe elements in the serum
of mice.
Metal ion Normal concentration in the blood mg/L After inject of folic acid mg/L After inject complex mg/L
Cu (mg/L) 1.18 5.00 ± 0.21 7± 0.6
Fe (mg/L) 2.1 9.2 ± 0.15 13.8 ± 0.8Bioinorganic Chemistry and Applications 5
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Figure 3: I.R. Spectrum of iron folate complex.
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Figure 4: TG and DTG of copper complex.
peaks over the temperature range (0–600◦C). The ﬁrst step
occurs from 50–170◦C corresponding to the loss of four
H2O molecules representing weight loss (obs. = 6.66% and
calc. = 6.61%). The second and third steps from 170◦C–
599◦C corresponding to the loss of C7H32N14O11(organic
part)molecules,representingweightloss(obs. =44.13%and
calc. = 44.79%). The last one over 600◦C was accompanied
by mass loss (obs.= 49.21% and calc. = 48.60%) as metallic
and carbon residue are the ﬁnal product.
The thermal decomposition of iron folate complex,
occurs completely in four steps. The ﬁrst step in the
range 50.7◦C–192.4◦C corresponding to the loss of 5 H2O
moleculesrepresentingweightloss(obs. = 8.92%andcalc.=
8.48%). The second and third steps from 218◦C–596◦C
corresponding to the loss of C7H31N14O11(organic part)
molecules representing weight loss (obs. = 46.3% and calc.=
45.9%). The last one over 600◦C was accompanied by mass
loss (obs.=44.74% and calc. = 44.77%) as metallic and
carbon residue is the ﬁnal product.
3.4. Biological Applications. Atomic absorption data (Tables
4 and 5) proved that the values for the concentration of
metal ion in blood in the presence of the folic acid are higher
than those in absence of the folic acid. This means that folic
acid withdraws the metal ion from the body forming the
complex in blood. It may be concluded that the folic acid in
the complexed form absorbed more eﬃcienty in the rodent
blood than the folic acid itself.
Inspection of the results shown in Table 4 reveals that
the copper and iron contents in mice blood increases
signiﬁcantly on feeding the rodents with folic acid copper
and iron complexes. The absorption of folic acid complexes
is much better than folic acid absorption itself shown in
Table 5.So,thesecomplexescanbeusedasanaloguesforfolic
acid alone.
This may be explained as being due to the high solubility
diﬀerences between folic acid which is considered as an
insoluble material, and its copper and iron complexes are
shown in Table 1.
4. Conclusion
The complexation between transition metal ions as (Fe(III)
a n dC u( I I ) )w i t hf o l i ca c i dr e s u l t e di nt h ef o r m a t i o n( 1:2 )
molar ratio (metal : folic acid). Folic acid acts as a bidentate
ligand via two monodentate carboxylate groups giving the
general formula: [M(FO)2 (H2O)n]·xH2O, where FO =
folate anion; n= 2a n dx = 2 or 3. The resulted folate com-
pounds were assigned by infrared, optical measurements.
Thermogravimetric analysis and atomic absorption of folate
complexes. The transition metals folic acid complexes are
more preferred than folic acid itself as a drug in the human
body because the absorption eﬃciencies of the transition
metal complexes are higher than those the folic acid.
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